Login / Signup
Melek S Aksun
(M S Aksun, S Aksun)
ORCID
Publication Activity (10 Years)
Years Active: 2020-2023
Publications (10 Years): 3
Top Topics
Free Survival
Prognostic Factors
Childhood Cancer
Replacement Therapy
Top Venues
Biomarkers in medicine
Journal of endocrinological investigation
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Melek S Aksun
,
N C Sonu
,
S Aygun
,
U N Karakulak
,
Sezcan Mumusoglu
,
Bulent Okan Yildiz
Alterations of cardiometabolic risk profile in polycystic ovary syndrome: 13 years follow-up in an unselected population.
Journal of endocrinological investigation
(2023)
Deniz Can Guven
,
Oktay Halit Aktepe
,
Hakan Taban
,
Burak Yasin Aktaş
,
Gurkan Guner
,
Hasan C Yildirim
,
Taha Koray Sahin
,
Melek S Aksun
,
Omer Dizdar
,
Sercan Aksoy
,
Mustafa Erman
,
Şuayib Yalçin
,
Saadettin Kılıçkap
Lower prognostic nutritional index is associated with poorer survival in patients receiving immune checkpoint inhibitors.
Biomarkers in medicine
15 (13) (2021)
Melek S Aksun
,
E Ucgul
,
Taha Koray Sahin
,
Deniz Can Guven
,
S Aksoy
Nivolumab for the salvage treatment of desperate germ cell tumor: A case report.
Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
27 (6) (2020)